Unity Biotechnology saw strong gains in the market on Thursday after the CEO appeared on CNBC. While the company's story is a compelling one, it is in very early stages and risks are high. The company ...
Unity Software (U) shares traded about 1.17% lower at roughly $40.47 on Wednesday, extending a weekly decline of more than 6%. The weakness comes despite strong second-quarter earnings, suggesting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results